Keywords: astrazeneca, switches, corporate, brokers, anglo-swedish, drugmaker, dumped

AstraZeneca switches corporate brokers

Article | 13 December 2004

Anglo-Swedish drugmaker AstraZeneca has dumped Credit Suisse First Boston and Merrill Lynch as corporate brokers, replacing them with Deutsche Bank ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in